SAMSUNG BIOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 770,000 KRW | -1.28% |
|
-1.41% | +1.32% |
| Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
| Apr. 25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 817,000.00 | 859,000.00 | 859,000.00 |
| Spread/Res. | -5.75% | -10.36% | -10.36% |
| Spread/Supp. | +3.49% | +10.32% | +1.32% |
| Support | 744,000.00 | 698,000.00 | 760,000.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- A207940 Stock
- Charts Samsung Biologics Co.,Ltd.
